Robeco Institutional Asset Management B.V. Exelixis, Inc. Transaction History
Robeco Institutional Asset Management B.V.
- $51.9 Billion
- Q4 2024
A detailed history of Robeco Institutional Asset Management B.V. transactions in Exelixis, Inc. stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 505,289 shares of EXEL stock, worth $17.2 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
505,289
Previous 483,064
4.6%
Holding current value
$17.2 Million
Previous $12.5 Million
34.23%
% of portfolio
0.03%
Previous 0.03%
Shares
10 transactions
Others Institutions Holding EXEL
# of Institutions
509Shares Held
243MCall Options Held
2.54MPut Options Held
2.29M-
Black Rock Inc. New York, NY33.5MShares$1.14 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.3MShares$1 Billion0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA25.4MShares$867 Million3.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.4MShares$524 Million0.63% of portfolio
-
State Street Corp Boston, MA11.4MShares$391 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...